Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains

Journal of Biological Chemistry

Volumn 288, Issue 44, 2013, Pages 32004-32019

  Kumari, Ranju ^a   Castillo, Catherine ^a   Francesconi, Anna ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVITY-DEPENDENT; COGNITIVE DEFICITS; CRITICAL FUNCTIONS; G PROTEIN COUPLED RECEPTORS; MEMBRANE CHOLESTEROL; METABOTROPIC GLUTAMATE RECEPTORS; POSITIVE ALLOSTERIC MODULATOR; SYNAPTIC PLASTICITY;

AMINO ACIDS; ENZYME ACTIVITY;

CHOLESTEROL;

AMINO ACID; CHOLESTEROL; LIPID; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ALLOSTERISM; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPID MEMBRANE; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN MOTIF; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CHOLESTEROL; CRAC MOTIF; ERK; GLUTAMATE RECEPTORS METABOTROPIC; LIPID RAFT; PROTEIN MOTIFS;

ALLOSTERIC REGULATION; AMINO ACID MOTIFS; ANIMALS; CHOLESTEROL; FRAGILE X SYNDROME; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE MICRODOMAINS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84887081316     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.475863     Document Type: Article

References (82)

1. Niswender, C. M., and Conn, P. J. (2010) Metabotropic glutamate receptors. Physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295-322
2. Anwyl, R. (2009) Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 56, 735-740
3. Lüscher, C., and Huber, K. M. (2010) Group1 mGluR-dependent synaptic long-term depression. Mechanisms and implications for circuitry and disease. Neuron 65, 445-459
4. Snyder, E. M., and Philpot., B. D., Huber, K. M., Dong, X., Fallon, J. R., and Bear, M. F. (2001) Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4, 1079-1085 (Pubitemid 34116552)
5. Waung, M. W., and Huber, K. M. (2009) Protein translation in synaptic plasticity. mGluR-LTD, fragile X. Curr. Opin. Neurobiol. 19, 319-326
6. Catania, M. V., D'Antoni, S., Bonaccorso, C. M., Aronica, E., Bear, M. F., and Nicoletti, F. (2007) Group I metabotropic glutamate receptors. A role in neurodevelopmental disorders? Mol. Neurobiol. 35, 298-307 (Pubitemid 350129691)
7. Dölen, G., and Bear, M. F. (2008) Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J. Physiol. 586, 1503-1508 (Pubitemid 351404955)
8. Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., and Bear., M. F., and Lindemann, L. (2012) Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74, 49-56
9. Huber, K. M., and Gallagher., S. M., Warren, S. T., and Bear, M. F. (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U.S.A. 99, 7746-7750 (Pubitemid 34568762)
10. Wang, J. Q., and Fibuch., E. E., and Mao, L. (2007) Regulation of mitogen-activated protein kinases by glutamate receptors. J. Neurochem. 100, 1-11 (Pubitemid 46090772)
11. Hou, L., and Klann, E. (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24, 6352-6361 (Pubitemid 38944226)
12. Lingwood, D., and Simons, K. (2010) Lipid rafts as a membrane-organizing principle. Science 327, 46-50
13. Levental, I., Grzybek, M., and Simons, K. (2010) Greasing their way. Lipid modifications determine protein association with membrane rafts. Biochemistry 49, 6305-6316
14. Gao, X., and Lowry., P. R., Zhou, X., Depry, C., Wei, Z., and Wong., G. W., and Zhang, J. (2011) PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proc. Natl. Acad. Sci. U.S.A. 108, 14509-14514
15. Simons, K., and Toomre, D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39
16. Burgueño, J., Enrich, C., Canela, E. I., Mallol, J., Lluis, C., Franco, R., and Ciruela, F. (2003) Metabotropic glutamate type 1a receptor localizes in low density caveolin-rich plasma membrane fractions. J. Neurochem. 86, 785-791 (Pubitemid 36988792)
17. Francesconi, A., Kumari, R., and Zukin, R. S. (2009) Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar/lipid raft pathway. J Neurosci 29, 3590-3602
18. Ito, I., Kohda, A., Tanabe, S., Hirose, E., Hayashi, M., Mitsunaga, S., and Sugiyama, H. (1992) 3, 5-Dihydroxyphenyl-glycine. A potent agonist of metabotropic glutamate receptors. Neuroreport 3, 1013-1016
19. Litschig, S., Gasparini, F., Rueegg, D., Stoehr, N., and Flor., P. J., Vranesic, I., Prézeau, L., Pin, J. P., Thomsen, C., and Kuhn, R. (1999) CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol. Pharmacol. 55, 453-461 (Pubitemid 29128101)
20. Carroll, F. Y., Stolle, A., Beart, P. M., Voerste, A., Brabet, I., Mauler, F., Joly, C., Antonicek, H., Bockaert, J., Müller, T., Pin, J. P., and Prézeau, L. (2001) BAY36-7620. A potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol. Pharmacol. 59, 965-973 (Pubitemid 32381574)
21. Kumari, R., and Francesconi, A. (2011) Identification of GPCR localization in detergent-resistant membranes. Methods Mol. Biol. 746, 411-423
22. Lingwood, D., and Simons, K. (2007) Detergent resistance as a tool in membrane research. Nat. Protoc. 2, 2159-2165 (Pubitemid 351565854)
23. Francesconi, A., and Duvoisin, R. M. (1998) Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J. Biol. Chem. 273, 5615-5624 (Pubitemid 28124031)
24. 3H]quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. J. Neurochem. 75, 2590-2601
25. Simons, K., and Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-572 (Pubitemid 27248754)
26. Lichtenberg, D., Goñi, F. M., and Heerklotz, H. (2005) Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem. Sci. 30, 430-436 (Pubitemid 41033238)
27. Prézeau, L., Gomeza, J., Ahern, S., Mary, S., Galvez, T., Bockaert, J., and Pin, J. P. (1996) Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity. Mol. Pharmacol. 49, 422-429
28. Hong, Y. H, Kim, J. Y., and Lee., J. H., Chae, H. G., Jang, S. S., Jeon, J. H, Kim, C. H, Kim, J., and Kim, S. J. (2009) Agonist-induced internalization of mGluR1α is mediated by caveolin. J. Neurochem. 111, 61-71
29. Allen, J. A., Halverson-Tamboli, R. A., and Rasenick, M. M. (2007) Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 8, 128-140 (Pubitemid 46146951)
30. Patel, H. H., Murray, F., and Insel, P. A. (2008) Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu. Rev. Pharmacol. Toxicol. 48, 359-391 (Pubitemid 351738158)
31. Lajoie, P., and Goetz., J. G., Dennis, J. W., and Nabi, I. R. (2009) Lattices, rafts, and scaffolds. Domain regulation of receptor signaling at the plasma membrane. J. Cell Biol. 185, 381-385
32. Parton, R. G., and Simons, K. (2007) The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8, 185-194
33. Liu, P., Rudick, M., and Anderson, R. G. (2002) Multiple functions of caveolin-1. J. Biol. Chem. 277, 41295-41298 (Pubitemid 35257426)
34. Kong, M. M., Hasbi, A., Mattocks, M., Fan, T., O'Dowd, B. F., and George, S. R. (2007) Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Mol. Pharmacol. 72, 1157-1170 (Pubitemid 350012590)
35. Hill, M. M., Bastiani, M., Luetterforst, R., Kirkham, M., Kirkham, A., Nixon, S. J., Walser, P., Abankwa, D., Oorschot, V. M., Martin, S., and Hancock., J. F., and Parton, R. G. (2008) PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113-124
36. Kaiser, H. J., Orłowski, A., Róg, T., and Nyholm., T. K., Chai, W., Feizi, T., Lingwood, D., Vattulainen, I., and Simons, K. (2011) Lateral sorting in model membranes by cholesterol-mediated hydrophobic matching. Proc. Natl. Acad. Sci. U.S.A. 108, 16628-16633
37. Frisz, J. F., Lou, K., Klitzing, H. A., and Hanafin., W. P., Lizunov, V., Wilson, R. L., and Carpenter., K. J., Kim, R., Hutcheon, I. D., Zimmerberg, J., and Weber., P. K., and Kraft, M. L. (2013) Direct chemical evidence for sphingolipid domains in the plasma membranes of fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 110, E613-E622
38. Christian, A. E., and Haynes., M. P., Phillips, M. C, and Rothblat, G. H. (1997) Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38, 2264-2272 (Pubitemid 27495385)
39. sα. J. Biol. Chem. 268, 25001-25008 (Pubitemid 23335521)
40. Levental, I., Lingwood, D., Grzybek, M., Coskun, U., and Simons, K. (2010) Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. U.S.A. 107, 22050-22054
41. Ren, J., Wen, L., Gao, X., Jin, C, Xue, Y., and Yao, X. (2008) CSS-Palm 2.0. An updated software for palmitoylation sites prediction. Protein Eng. Des. Sel. 21, 639-644
42. Alaluf, S., and Mulvihill., E. R., and McIlhinney, R. A. (1995) The metabotropic glutamate receptor mGluR4, but not mGluR1α, is palmitoylated when expressed in BHK cells. J. Neurochem 64, 1548-1555
43. Epand, R. M. (2008) Proteins and cholesterol-rich domains. Biochim. Biophys. Acta 1778, 1576-1582
44. Zheng, H., Chu, J., Qiu, Y., Loh, H. H., and Law, P. Y. (2008) Agonistselective signaling is determined by the receptor location within the membrane domains. Proc. Natl. Acad. Sci. U.S.A. 105, 9421-9426
45. Kirsch, C, and Eckert., G. P., and Mueller, W. E. (2003) Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem. Pharmacol. 65, 843-856 (Pubitemid 36293701)
46. Ponce, J., de la Ossa, N. P., Hurtado, O., Millan, M., Arenillas, J. F., Dávalos, A., and Gasull, T. (2008) Simvastatin reduces the association of NMDA receptors to lipid rafts. A cholesterol-mediated effect in neuroprotection. Stroke 39, 1269-1275 (Pubitemid 351440701)
47. Munro, S. (2003) Lipid rafts. Elusive or illusive? Cell 115, 377-388
48. Silvius, J. R. (2005) Partitioning of membrane molecules between raft and non-raft domains. Insights from model-membrane studies. Biochim. Biophys. Acta 1746, 193-202 (Pubitemid 41815016)
49. Eggeling, C, Ringemann, C, Medda, R., Schwarzmann, G., Sandhoff, K., Polyakova, S., and Belov., V. N., Hein, B., von Middendorff, C, Schönle, A., and Hell, S. W. (2009) Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 457, 1159-1162
50. Foster, L. J., De Hoog, C. L., and Mann, M. (2003) Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. U.S.A. 100, 5813-5818 (Pubitemid 36576890)
51. Bhatnagar, A., and Sheffler., D. J., Kroeze, W. K., Compton-Toth, B., and Roth, B. L. (2004) Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gα-coupled protein receptors. J. Biol. Chem. 279, 34614-34623 (Pubitemid 39318091)
52. s/adenylyl cyclase signaling. Mol. Pharmacol. 76, 1082-1093
53. Pontier, S. M., Percherancier, Y., Galandrin, S., Breit, A., Galés, C, and Bouvier, M. (2008) Cholesterol-dependent separation of the β2-adrenergic receptor from its partners determines signaling efficacy. Insight into nanoscale organization of signal transduction. J. Biol. Chem. 283, 24659-24672
54. Zheng, H., and Pearsall., E. A., Hurst, D. P., Zhang, Y., Chu, J., Zhou, Y., Reggio, P. H, Loh, H. H., and Law, P. Y. (2012) Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling. BMC Cell Biol. 13, 6
55. Escribá, P. V., Wedegaertner, P. B., Goñi, F. M., and Vögler, O. (2007) Lipid-protein interactions in GPCR-associated signaling. Biochim. Biophys. Acta 1768, 836-852 (Pubitemid 46452537)
56. Patel, H. H., Murray, F., and Insel, P. A. (2008) G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb. Exp. Pharmacol. 186, 167-184
57. Takayasu, Y., Takeuchi, K., Kumari, R., Bennett, M. V., and Zukin., R. S., and Francesconi, A. (2010) Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses. Proc. Natl. Acad. Sci. U.S.A. 107, 21778-21783
58. Björk, K., and Svenningsson, P. (2011) Modulation of monoamine receptors by adaptor proteins and lipid rafts. Role in some effects of centrally acting drugs and therapeutic agents. Annu. Rev. Pharmacol. Toxicol. 51, 211-242
59. Kaiser, H. J., Lingwood, D., Levental, I., Sampaio, J. L., Kalvodova, L., Rajendran, L., and Simons, K. (2009) Order of lipid phases in model and plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 106, 16645-16650
60. Lingwood, D., Binnington, B., Róg, T., Vattulainen, I., Grzybek, M., Coskun, U., Lingwood, C. A., and Simons, K. (2011) Cholesterol modulates glycolipid conformation and receptor activity. Nat. Chem. Biol. 7, 260-262
61. Cherezov, V., Rosenbaum, D.M., Hanson, M. A., Rasmussen, S. G., and Thian., F. S., Kobilka, T. S., Choi, H.J., Kuhn, P., Weis, W. I., and Kobilka., B. K., and Stevens, R. C. (2007) High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318, 1258-1265 (Pubitemid 350172884)
62. Hanson, M. A., Cherezov, V., Griffith, M. T., and Roth., C. B., Jaakola, V. P., Chien, E. Y., Velasquez, J., Kuhn, P., and Stevens, R. C. (2008) A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor. Structure 16, 897-905 (Pubitemid 351778384)
63. Liu, W., Chun, E., Thompson, A. A., Chubukov, P., Xu, F., Katritch, V., Han, G. W., and Roth., C. B., Heitman, L. H, IJzerman, A. P., Cherezov, V., and Stevens, R. C. (2012) Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232-236
64. Chang, T. Y., Chang, C. C, Ohgami, N., and Yamauchi, Y. (2006) Cholesterol sensing, trafficking, and esterification. Annu. Rev. CellDev. Biol. 22, 129-157
65. Barrett, P. J., Song, Y., Van Horn, W. D., Hustedt, E. J., Schafer, J. M., Hadziselimovic, A., Beel, A. J., and Sanders, C. R. (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336, 1168-1171
66. Jafurulla, M., Tiwari, S., and Chattopadhyay, A. (2011) Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein-coupled receptors. Biochem. Biophys. Res. Commun. 404, 569-573
67. Oddi, S., Dainese, E., Fezza, F., Lanuti, M., Barcaroli, D., De Laurenzi, V., Centonze, D., and Maccarrone, M. (2011) Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J. Neurochem. 116, 858-865
68. Hemstapat, K., de Paulis, T., Chen, Y., Brady, A. E., and Grover., V. K., Alagille, D., Tamagnan, G. D., and Conn, P. J. (2006) A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators. Mol. Pharmacol. 70, 616-626 (Pubitemid 44092322)
69. Bruno, A., Costantino, G., de Fabritiis, G., Pastor, M., and Selent, J. (2012) Membrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCR. PLoS ONE 7, e42023
70. El Moustaine, D., Granier, S., Doumazane, E., Scholler, P., Rahmeh, R., Bron, P., Mouillac, B., Banères, J. L., Rondard, P., and Pin, J. P. (2012) Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling. Proc. Natl. Acad. Sci. U.S.A. 109, 16342-16347
71. Oates, J., and Watts, A. (2011) Uncovering the intimate relationship between lipids, cholesterol, and GPCR activation. Curr. Opin. Struct. Biol. 21, 802-807
72. Parmentier, M. L., and Pin., J. P., Bockaert, J., and Grau, Y. (1996) Cloning and functional expression of a Drosophila metabotropic glutamate receptor expressed in the embryonic CNS. J. Neurosci. 16, 6687-6694 (Pubitemid 26359352)
73. Eroglu, C, Brugger, B., Wieland, F., and Sinning, I. (2003) Glutamatebinding affinity of Drosophila metabotropic glutamate receptor is modulated by association with lipid rafts. Proc. Natl. Acad. Sci. U.S.A. 100, 10219-10224 (Pubitemid 37071859)
74. Eroglu, C, Cronet, P., Panneels, V., Beaufils, P., and Sinning, I. (2002) Functional reconstitution of purified metabotropic glutamate receptor expressed in the fly eye. EMBO Rep. 3, 491-496 (Pubitemid 34567439)
75. Gerber, U., and Gee., C. E., and Benquet, P. (2007) Metabotropic glutamate receptors. Intracellular signaling pathways. Curr. Opin. Pharmacol. 7, 56-61 (Pubitemid 46238032)
76. Emery, A. C., and DiRaddo., J. O., Miller, E., Hathaway, H. A., Pshenichkin, S., and Takoudjou., G. R., Grajkowska, E., Yasuda, R. P., and Wolfe., B. B., and Wroblewski, J. T. (2012) Ligand bias at metabotropic glutamate 1a receptors. Molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling. Mol. Pharmacol. 82, 291-301
77. Nicodemo, A. A., Pampillo, M., Ferreira, L. T., and Dale., L. B., Cregan, T., Ribeiro, F. M., and Ferguson, S. S. (2010) Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation. Mol. Brain 3, 4
78. Gallagher, S. M., and Daly., C. A., Bear, M. F., and Huber, K. M. (2004) Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1. J. Neurosci. 24, 4859-4864 (Pubitemid 38668210)
79. Huang, S., Cao, J., Jiang, M., Labesse, G., Liu, J., Pin, J. P., and Rondard, P. (2011) Interdomain movements in metabotropic glutamate receptor activation. Proc. Natl. Acad. Sci. U.S.A. 108, 15480-15485
80. Yanagawa, M., Yamashita, T., and Shichida, Y. (2009) Activation switch in the transmembrane domain of metabotropic glutamate receptor. Mol. Pharmacol. 76, 201-207
81. Xiang, Y., and Rybin., V. O., Steinberg, S. F., and Kobilka, B. (2002) Caveolar localization dictates physiologic signaling of β 2-adrenoceptors in neonatal cardiac myocytes. J. Biol. Chem. 277, 34280-34286
82. Osterweil, E. K., and Chuang., S. C., Chubykin, A. A., Sidorov, M., Bianchi, R., and Wong., R. K., and Bear, M. F. (2013) Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron 77, 243-250